PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-73.67%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-89.61%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-90.91%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-90.91%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.68%
OCF growth under 50% of CRON.TO's 234.45%. Michael Burry might suspect questionable revenue recognition or rising costs.
98.68%
FCF growth similar to CRON.TO's 94.16%. Walter Schloss would attribute it to parallel capital spending and operational models.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
97.37%
10Y OCF/share CAGR under 50% of CRON.TO's 199.63%. Michael Burry would worry about a persistent underperformance in cash creation.
97.37%
5Y OCF/share CAGR is similar to CRON.TO's 106.62%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
97.37%
3Y OCF/share CAGR at 75-90% of CRON.TO's 115.92%. Bill Ackman would press for improvements in margin or overhead to catch up.
45.31%
Positive 10Y CAGR while CRON.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
45.31%
5Y net income/share CAGR at 50-75% of CRON.TO's 66.60%. Martin Whitman might see a shortfall in operational efficiency or brand power.
45.31%
Positive short-term CAGR while CRON.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-18.10%
Negative equity/share CAGR over 10 years while CRON.TO stands at 1410.50%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-18.10%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-18.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.46%
AR growth well above CRON.TO's 23.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-2.28%
Negative asset growth while CRON.TO invests at 1.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.94%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.67%
SG&A growth well above CRON.TO's 8.16%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.